MedPath

Comparison of the effect of the calcium citrate supplement with normal calcium diet on metabolic risk factors in recurrent calcium stone formers with hyperoxaluria

Phase 3
Recruiting
Conditions
Recurrent calcium stone formers with hyperoxaluria.
Calculus of kidney
N20.0
Registration Number
IRCT20160206026406N3
Lead Sponsor
Shahid Beheshti University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
66
Inclusion Criteria

Recurrent stone former
Hyperoxaluria (24hr Urine Oxalate between 40-80 mg)
Baseline dietary calcium intake less than 800 mg/day
The desire to collaborate in the study

Exclusion Criteria

Enteric or primary hyperoxaluria (24 hours urine oxalate more than 80 mg)
Taking Thiazides or any medicine that has an effect on calcium metabolism
Taking any medicine that has an effect on oxalate metabolism
Taking vitamin B6
Hepatitis, diabetes, thyroid diseases, hyperparathyroidism, immunological diseases, cancers, chronic diarrhea, chronic kidney diseases and urinary tract infection
Pregnancy and lactation

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
24hr Urine Oxalate. Timepoint: Before the intervention, 8 weeks after intervention. Method of measurement: Enzymatic method.;Calcium oxalate supersaturation. Timepoint: Before the intervention, 8 weeks after intervention. Method of measurement: Calculation by LITHORISK software.
Secondary Outcome Measures
NameTimeMethod
rine pH. Timepoint: Before the intervention, 8 weeks after intervention. Method of measurement: pH meter.;24 hour urine oxalate. Timepoint: Before the intervention, 8 weeks after intervention. Method of measurement: Enzymatic method.
© Copyright 2025. All Rights Reserved by MedPath